Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/21/2025

Radiation-Induced Lung Injury Prevention and Management

Prevention Strategies

  • The American Cancer Society recommends limiting lung exposure to no more than 3-3.5 cm of lung tissue in the treatment field to minimize radiation pneumonitis risk 1, 2
  • The National Comprehensive Cancer Network suggests using CT-based treatment planning to accurately identify and minimize lung and heart volumes exposed to radiation 2
  • Intensity-modulated radiotherapy (IMRT) allows more conformal high-dose delivery and improved coverage while sparing normal tissues, but requires strict dose constraints to prevent excessively high risk of fatal pneumonitis 4, 5
  • When using IMRT, the mean lung dose should be kept as low as possible, preferably less than 8.5 Gy, and minimize the volume of contralateral lung receiving low-dose radiotherapy (e.g., 5 Gy) 4, 5

Standard Dosing Protocols

  • The standard dose for whole breast irradiation is 45-50 Gy in 23-25 fractions (1.8-2.0 Gy per fraction) 2
  • The preferred hypofractionated regimen is 40-42.5 Gy in 15-16 fractions 2
  • For chest wall post-mastectomy, the target includes ipsilateral chest wall, mastectomy scar, and drain sites, with a dose of 46-50 Gy in 23-25 fractions 2

Critical Pitfalls to Avoid

  • Never combine techniques that result in excessive cardiac irradiation, as this increases late cardiac mortality 2
  • Do not exceed 3-3.5 cm of lung in the treatment field to prevent pneumonitis 1, 2
  • Avoid bolus use during treatment 1
  • Ensure uniform dose distribution to minimize normal tissue toxicity 2

REFERENCES

2

Breast Radiotherapy Guidelines [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

3

malignant pleural mesothelioma. [LINK]

Journal of the National Comprehensive Cancer Network : JNCCN, 2012

4

malignant pleural mesothelioma. [LINK]

Journal of the National Comprehensive Cancer Network : JNCCN, 2012